Depression and Anxiety Trial, Recruiting NCT06746155 Sponsor: Abraham Nunes Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06746155
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old and are seen as an outpatient (not staying overnight in a hospital).
  • You have been diagnosed with Major Depressive Disorder (MDD) based on a structured clinical interview.
  • In your current or most recent episode of depression, you have responded to treatment (such as medication or other therapies), or your depression is currently in remission; remission must have been reached on or after May 1, 2023.
  • Your depression symptoms are currently low, based on a specific symptom rating scale score (confirm with trial site).
  • You are able and willing to complete self-reported questionnaires in English.
  • You are willing to wear a wrist device (similar to a fitness tracker) throughout the study to track your movement and sleep patterns.

Who may not be able to join:

  • You have ever been diagnosed with Bipolar I or Bipolar II disorder, schizophrenia, or schizoaffective disorder.
  • You are currently considered to be at an elevated risk of suicide, as assessed by a clinician.
  • You have a significant neurological condition, or a serious head injury involving prolonged loss of consciousness, a severe coma score at the time of injury, or memory loss lasting more than 24 hours, or another unstable medical condition.
  • You have any other condition that, in the researcher's opinion, could interfere with your participation in the study (confirm with trial site).
  • You are employed by, closely related to, or otherwise directly connected to the researcher running this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abraham Nunes
Registry
ClinicalTrials.gov
Start date
27 December 2024
Est. completion
1 October 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Time-to-relapse

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov